Quarterly report pursuant to Section 13 or 15(d)

Interim Consolidated Statements of Cash Flow

v3.23.3
Interim Consolidated Statements of Cash Flow - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities    
Net income (loss) for the period $ (25,184) $ (12,243)
Items not affecting cash:    
Stock based compensation 779 964
Net realizable value adjustments 8,158 5,039
Amortization of mineral properties 828 936
Depreciation of capital assets 1,546 1,362
Accretion expense 371 339
Amortization of deferred loan costs 33 34
Provision for reclamation 0 (1)
Warrant liability revaluation loss (gain) 4,155 (1,620)
Unrealized foreign exchange loss (gain) (329) (27)
Changes in non-cash working capital:    
Accounts receivable (5,600) 0
Inventory (2,956) (7,019)
Prepaid expenses (565) (481)
Accounts payable and accrued liabilities 2,105 381
Cash provided by used in operating activities (16,659) (12,336)
Investing activities    
Purchase of capital assets (1,923) (213)
Cash provided by used in investing activities (1,923) (213)
Financing activities    
Issuance of common shares and warrants for cash 46,637 3,313
Share issue costs (3,002) (83)
Proceeds from exercise of warrants and stock options 969 3,279
RSU redeemed for cash (81) 0
Repayment of debt 4,027 0
Cash provided by used in financing activities 40,496 6,509
Effects of foreign exchange rate changes on cash 7 (130)
Increase (decrease) in cash, cash equivalents, and restricted cash 21,921 (6,170)
Beginning cash, cash equivalents, and restricted cash 41,140 54,155
Ending cash, cash equivalents, and restricted cash $ 63,061 $ 47,985